Expert Analysis

Bid Protest Spotlight: Documentation, Overrides, Eligibility

Recent decisions by the U.S. Court of Federal Claims and the U.S. Government Accountability Office illustrate the ... (more story)

Shutdown Imperils Telehealth Access For Medicare Patients

The federal government shutdown that commenced on Oct. 1 coincided with the expiration of certain telehealth flexi... (more story)

Mass. Ruling May Pave New Avenue To Target Subpoenas

A Massachusetts federal court’s recent decision to quash a subpoena seeking information on gender-affirming care a... (more story)

Deals & Corporate Governance More

Full 3rd Circ. Won't Rethink $45M CareDx False Ad Case

The Third Circuit on Tuesday turned down medical testing company CareDx's request to have a full panel mull whether to reinstate a $45 million jury award in a false advertisement case over genetic testing tech... (more story)

Colo. Biz Accuses VA Of Ignoring Veteran-Owned Suppliers

A Colorado company accused the U.S. Department of Veterans Affairs of improperly greenlighting purchases of electrocardiogram leads from a large overseas business when American-made items are available from it... (more story)

Judges Back Ga. County's Use Of Outside Attys In Opioid Suit

The Georgia Court of Appeals has backed the dismissal of a lawsuit by Publix Supermarkets claiming a metro Atlanta county unconstitutionally hired outside counsel to pursue opioid litigation against the grocer... (more story)

Covington, Sidley Guide $700M BioCryst Allergic Disease Deal

BioCryst Pharmaceuticals Inc. will purchase Astria Therapeutics Inc., a biopharmaceutical company focused on therapies for allergic and immunologic diseases, in a cash and stock deal worth about $700 million, ... (more story)

DOJ Can't Pause Review Of UnitedHealth Deal Amid Shutdown

A Maryland federal judge rejected the U.S. Department of Justice's bid to stay its recently settled case with UnitedHealth over the company's merger with Amedisys because of the government shutdown and lapse i... (more story)

ATyr Pharma Faces Investor Suit Over Failed Drug Trial

Rare disease biotech aTyr Pharma Inc. and its CEO have been hit with a proposed shareholder class action accusing them of misleading the public about the efficacy of aTyr's lung disease treatment for several m... (more story)

Digital Health & Technology More

Spencer Fane Attys Talk Med Spas And Healthcare Law

Providers and investors attracted to a growing medical spa industry might be surprised to discover that aesthetic treatments like Botox and fillers that don't require a doctor still come with a robust set of h... (more story)

Ōura Valuation Soars To $11B After $900M Financing Round

Fitness-tracking ring maker Ōura on Tuesday revealed it had reached a roughly $11 billion valuation after securing over $900 million in a funding round, which it says will help it develop new technologies, spe... (more story)

High Court Won't Hear FDA Stem Cell Regulation Fight

The U.S. Supreme Court on Tuesday declined to review a circuit court holding that a stem cell treatment derived from a patient's own tissue is subject to Food, Drug and Cosmetic Act regulations.

Infosys' Counterclaims Against Competitor Tossed For Now

A Texas federal court dismissed counterclaims from Infosys Ltd. accusing Cognizant TriZetto Software Group Inc. of monopolizing a market for healthcare software and related services after finding the allegatio... (more story)

Pharma Co. Escapes Suit Over Ex-CEO's Alleged Misconduct

Exscientia PLC on Friday won dismissal of a proposed class action related to the termination of its CEO after claims emerged that he participated in inappropriate workplace relationships, with the court findin... (more story)

Ga. Medical Billing Practice Faces Data Breach Class Action

A Georgia-based medical billing practice was hit with a proposed class action in federal court over a September data breach that allegedly exposed the personally identifiable and protected health information o... (more story)

Policy & Compliance More

Providers Bring No Surprises Act Fight To High Court

Two air ambulance providers asked the U.S. Supreme Court to allow them to use the courts to collect on out-of-network billing dispute resolution awards granted under the No Surprises Act, saying that without j... (more story)

6th Circ. Won't Revive Allergy Tester's Antitrust Case

The Sixth Circuit refused to revive an allergy testing and treatment company's antitrust case accusing an insurer and a medical group of conspiring to squeeze it out of the market, after finding that doctors a... (more story)

State Fraud Units Step Up To Police Medicaid

The loss of seasoned prosecutors at federal agencies, coupled with the Trump administration’s intense focus on immigration, is undermining the government’s ability to police complex healthcare fraud schemes. S... (more story)

Meet HHS General Counsel Michael Stuart

Michael Stuart, a former chief federal prosecutor for West Virginia, has been confirmed by the U.S. Senate to serve as general counsel for the Department of Health and Human Services, where he has promised to ... (more story)

Humana's 2025 Medicare Ratings Sound, Judge Says

A Texas federal judge on Tuesday upheld the Centers for Medicare & Medicaid Services' 2025 star ratings for some of Humana Inc.'s Medicare Advantage plans, saying the agency had the right to hand down a poor r... (more story)

Expert Warns Of Autism Claims 'Tsunami' For Vax Program

Drawing on federal data on profound autism, a law professor and former Arnold & Porter partner predicts that a federal declaration that childhood vaccines cause autism could generate roughly $30 billion in new... (more story)